Jump to navigation
Your LLMW or eligible NARM waste must meet Land Disposal Restriction (LDR) treatment standards specified in 40 CFR part 268, subpart D.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 1006 - Applications and furnishing of information
§ 2002 - Transfer of hospitals and facilities to State or private institutions; conditions and restrictions; failure to meet requirements
§ 3001 - Congressional declaration of objectives
§ 3014 - Repealed. Pub. L. 97–115, § 2(e)(1), Dec. 29, 1981, 95 Stat. 1596
§ 3017 - Evaluation of programs
§ 6905 - Application of chapter and integration with other Acts
§ 6906 - Financial disclosure
§ 6912 - Authorities of Administrator
§ 6921 - Identification and listing of hazardous waste
§ 6922 - Standards applicable to generators of hazardous waste
§ 6924 - Standards applicable to owners and operators of hazardous waste treatment, storage, and disposal facilities
§ 6925 - Permits for treatment, storage, or disposal of hazardous waste
§ 6926 - Authorized State hazardous waste programs
§ 6927 - Inspections
§ 6934 - Monitoring, analysis, and testing
§ 6937 - Inventory of Federal agency hazardous waste facilities
Title 40 published on 2015-07-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 40 CFR Part 266 after this date.
Some pharmaceuticals are regulated as hazardous waste under the Resource Conservation and Recovery Act (RCRA) when discarded. Healthcare facilities that generate hazardous waste pharmaceuticals as well as associated facilities have reported difficulties complying with the Subtitle C hazardous waste regulations for a number of reasons. First, healthcare workers, whose primary focus is to provide care for patients, are not knowledgeable about the RCRA hazardous waste regulations, but are often involved in the implementation of the regulations. Second, a healthcare facility can have thousands of items in its formulary, making it difficult to ascertain which ones are hazardous wastes when disposed. Third, some active pharmaceutical ingredients are listed as acute hazardous wastes, which are regulated in small amounts. To facilitate compliance and to respond to these concerns, the U.S. Environmental Protection Agency (EPA or the Agency) is proposing to revise the regulations to improve the management and disposal of hazardous waste pharmaceuticals and tailor them to address the specific issues that hospitals, pharmacies and other healthcare-related facilities face. The revisions are also intended to clarify the regulation of the reverse distribution mechanism used by healthcare facilities for the management of unused and/or expired pharmaceuticals.